DCT

2:23-cv-01902

Actelion Pharma US Inc v. Alembic Pharma Ltd

General
Filed
04/04/23
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
64%
Defendant
Party
Attorney